Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...
Doing targeted COPD case finding as part of NHS lung cancer checks could save £33m over the next decade, research has shown.
Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback